Sunday, September 26, 2004


Yahoo! News - FDA Approves New Opioid-Based Pain Medicine
The new drug, called Palladone contains a controlled substance called hydromorphone and has "the potential for abuse," the agency said. It will be regulated by the Drug Enforcement Administration, according to the statement.

FDA officials said Palladone should only be used in patients, who are already taking opioid medicines, and who need to take at least 12 milligrams of the oral hydromorphone or its equivalent each day. The extended-release capsules are available in 12, 16, 24 and 32 milligram doses.

To help curb the possibility of abuse with Palladone, the company said it would provide "clear and appropriate labeling," educate healthcare professionals and "offer appropriate training to sales representatives," according to the FDA's statement.

Yes, "clear and appropriate labeling" has stopped many addicts, hasn't it?